266 related articles for article (PubMed ID: 24859981)
1. Targeted gene therapy and cell reprogramming in Fanconi anemia.
Rio P; Baños R; Lombardo A; Quintana-Bustamante O; Alvarez L; Garate Z; Genovese P; Almarza E; Valeri A; Díez B; Navarro S; Torres Y; Trujillo JP; Murillas R; Segovia JC; Samper E; Surralles J; Gregory PD; Holmes MC; Naldini L; Bueren JA
EMBO Mol Med; 2014 Jun; 6(6):835-48. PubMed ID: 24859981
[TBL] [Abstract][Full Text] [Related]
2. Overcoming reprogramming resistance of Fanconi anemia cells.
Müller LU; Milsom MD; Harris CE; Vyas R; Brumme KM; Parmar K; Moreau LA; Schambach A; Park IH; London WB; Strait K; Schlaeger T; Devine AL; Grassman E; D'Andrea A; Daley GQ; Williams DA
Blood; 2012 Jun; 119(23):5449-57. PubMed ID: 22371882
[TBL] [Abstract][Full Text] [Related]
3. Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors.
Suzuki NM; Niwa A; Yabe M; Hira A; Okada C; Amano N; Watanabe A; Watanabe K; Heike T; Takata M; Nakahata T; Saito MK
Stem Cells Transl Med; 2015 Apr; 4(4):333-8. PubMed ID: 25762002
[TBL] [Abstract][Full Text] [Related]
4. Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy.
Navarro S; Moleiro V; Molina-Estevez FJ; Lozano ML; Chinchon R; Almarza E; Quintana-Bustamante O; Mostoslavsky G; Maetzig T; Galla M; Heinz N; Schiedlmeier B; Torres Y; Modlich U; Samper E; Río P; Segovia JC; Raya A; Güenechea G; Izpisua-Belmonte JC; Bueren JA
Stem Cells; 2014 Feb; 32(2):436-46. PubMed ID: 24420904
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic gene editing in CD34
Diez B; Genovese P; Roman-Rodriguez FJ; Alvarez L; Schiroli G; Ugalde L; Rodriguez-Perales S; Sevilla J; Diaz de Heredia C; Holmes MC; Lombardo A; Naldini L; Bueren JA; Rio P
EMBO Mol Med; 2017 Nov; 9(11):1574-1588. PubMed ID: 28899930
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs.
Molina-Estevez FJ; Nowrouzi A; Lozano ML; Galy A; Charrier S; von Kalle C; Guenechea G; Bueren JA; Schmidt M
Curr Gene Ther; 2015; 15(6):550-62. PubMed ID: 26415575
[TBL] [Abstract][Full Text] [Related]
7. Brief report: human pluripotent stem cell models of fanconi anemia deficiency reveal an important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors.
Yung SK; Tilgner K; Ledran MH; Habibollah S; Neganova I; Singhapol C; Saretzki G; Stojkovic M; Armstrong L; Przyborski S; Lako M
Stem Cells; 2013 May; 31(5):1022-9. PubMed ID: 23280624
[TBL] [Abstract][Full Text] [Related]
8. Induced Pluripotency and Gene Editing in Fanconi Anemia.
Navarro S; Giorgetti A; Raya A; Tolar J
Curr Gene Ther; 2017; 16(5):321-328. PubMed ID: 28103772
[TBL] [Abstract][Full Text] [Related]
9. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.
Río P; Navarro S; Wang W; Sánchez-Domínguez R; Pujol RM; Segovia JC; Bogliolo M; Merino E; Wu N; Salgado R; Lamana ML; Yañez RM; Casado JA; Giménez Y; Román-Rodríguez FJ; Álvarez L; Alberquilla O; Raimbault A; Guenechea G; Lozano ML; Cerrato L; Hernando M; Gálvez E; Hladun R; Giralt I; Barquinero J; Galy A; García de Andoín N; López R; Catalá A; Schwartz JD; Surrallés J; Soulier J; Schmidt M; Díaz de Heredia C; Sevilla J; Bueren JA
Nat Med; 2019 Sep; 25(9):1396-1401. PubMed ID: 31501599
[TBL] [Abstract][Full Text] [Related]
10. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
[TBL] [Abstract][Full Text] [Related]
11. Generation of an induced pluripotent stem cell line that mimics the disease phenotypes from a patient with Fanconi anemia by conditional complementation.
Bharathan SP; Nandy K; Palani D; Janet A NB; Natarajan K; George B; Srivastava A; Velayudhan SR
Stem Cell Res; 2017 Apr; 20():54-57. PubMed ID: 28395741
[TBL] [Abstract][Full Text] [Related]
12. An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation.
Marion W; Boettcher S; Ruiz-Torres S; Lummertz da Rocha E; Lundin V; Morris V; Chou S; Zhao AM; Kubaczka C; Aumais O; Zhang Y; Shimamura A; Schlaeger TM; North TE; Ebert BL; Wells SI; Daley GQ; Rowe RG
Blood Adv; 2020 Oct; 4(19):4679-4692. PubMed ID: 33002135
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.
Galimi F; Noll M; Kanazawa Y; Lax T; Chen C; Grompe M; Verma IM
Blood; 2002 Oct; 100(8):2732-6. PubMed ID: 12351379
[TBL] [Abstract][Full Text] [Related]
14. Minimal conditioning in Fanconi anemia promotes multi-lineage marrow engraftment at 10-fold lower cell doses.
Haworth KG; Ironside C; Ramirez MA; Weitz S; Beard BC; Schwartz JD; Adair JE; Kiem HP
J Gene Med; 2018 Oct; 20(10-11):e3050. PubMed ID: 30129972
[TBL] [Abstract][Full Text] [Related]
15. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic
Lach FP; Singh S; Rickman KA; Ruiz PD; Noonan RJ; Hymes KB; DeLacure MD; Kennedy JA; Chandrasekharappa SC; Smogorzewska A
Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33172906
[TBL] [Abstract][Full Text] [Related]
16. Advances in Gene Therapy for Fanconi Anemia.
Río P; Navarro S; Bueren JA
Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
[TBL] [Abstract][Full Text] [Related]
17. Rapid lentiviral transduction preserves the engraftment potential of Fanca(-/-) hematopoietic stem cells.
Müller LU; Milsom MD; Kim MO; Schambach A; Schuesler T; Williams DA
Mol Ther; 2008 Jun; 16(6):1154-60. PubMed ID: 18398427
[TBL] [Abstract][Full Text] [Related]
18. Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2.
Zahnreich S; Weber B; Rösch G; Schindler D; Schmidberger H
DNA Repair (Amst); 2020 Dec; 96():102992. PubMed ID: 33069004
[TBL] [Abstract][Full Text] [Related]
19. In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice.
Río P; Segovia JC; Hanenberg H; Casado JA; Martínez J; Göttsche K; Cheng NC; Van de Vrugt HJ; Arwert F; Joenje H; Bueren JA
Blood; 2002 Sep; 100(6):2032-9. PubMed ID: 12200363
[TBL] [Abstract][Full Text] [Related]
20. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
